Shouval Roni, Nagler Arnon
Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Stem Cell Investig. 2017 May 24;4:39. doi: 10.21037/sci.2017.05.06. eCollection 2017.
Prospectively identifying patients who will gain maximal benefit from umbilical cord blood transplantation (UCBT) with minimal risk is a desirable unmet need. A complex network of parameters related to patient, disease, donor, and procedure all come into play. We review the prognostic role of patient-related risk factors in adults undergoing UCBT. Furthermore, since comprehensive prognostic models are lacking in UCBT, we suggest a framework for integrating patients' features in the development of prediction models for UCBT outcomes. Such models could contribute to patient selection, optimization of the various modifiable features in the process of UCBT, analysis of retrospective data, and design of interventions.
前瞻性地识别出能从脐带血移植(UCBT)中获得最大益处且风险最小的患者,是一个亟待满足的需求。与患者、疾病、供体和手术相关的一系列复杂参数都在其中发挥作用。我们回顾了患者相关风险因素在接受UCBT的成人患者中的预后作用。此外,由于UCBT缺乏全面的预后模型,我们提出了一个在UCBT结果预测模型开发中整合患者特征的框架。这样的模型有助于患者选择、优化UCBT过程中各种可改变的特征、分析回顾性数据以及设计干预措施。